288 related articles for article (PubMed ID: 26118442)
1. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.
Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B
Eur J Pharm Sci; 2015 Oct; 78():19-30. PubMed ID: 26118442
[TBL] [Abstract][Full Text] [Related]
2. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
3. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Huang RQ; Qu YH; Ke WL; Zhu JH; Pei YY; Jiang C
FASEB J; 2007 Apr; 21(4):1117-25. PubMed ID: 17218540
[TBL] [Abstract][Full Text] [Related]
4. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
[TBL] [Abstract][Full Text] [Related]
5. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
6. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
Thuy le T; Mallick S; Choi JS
Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
Huang R; Ke W; Han L; Li J; Liu S; Jiang C
Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
9. SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin.
Zarebkohan A; Najafi F; Moghimi HR; Hemmati M; Deevband MR; Kazemi B
Iran J Pharm Res; 2016; 15(4):629-640. PubMed ID: 28243262
[TBL] [Abstract][Full Text] [Related]
10. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers and the delivered drug: effect interference due to intravenous administration.
Vlasova MA; Rytkönen J; Riikonen J; Tarasova OS; Mönkäre J; Kovalainen M; Närvänen A; Salonen J; Herzig KH; Lehto VP; Järvinen K
Eur J Pharm Sci; 2014 Oct; 63():96-102. PubMed ID: 24964293
[TBL] [Abstract][Full Text] [Related]
12. Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage.
Hu Q; Chen Q; Yan X; Ding B; Chen D; Cheng L
Nanomedicine (Lond); 2018 Apr; 13(7):749-767. PubMed ID: 29528264
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.
Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588
[TBL] [Abstract][Full Text] [Related]
14. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
15. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.
Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS
Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111
[TBL] [Abstract][Full Text] [Related]
16. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
17. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
18. The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.
Shen W; van Dongen MA; Han Y; Yu M; Li Y; Liu G; Banaszak Holl MM; Qi R
Eur J Pharm Biopharm; 2014 Nov; 88(3):658-63. PubMed ID: 25083608
[TBL] [Abstract][Full Text] [Related]
19. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
20. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]